The studies have revealed that FM patients exhibit lower levels of the peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) and the mitochondrial transcription factor A (TFAM), whereas CFS patients did not display significant changes in these proteins. Here, TFAM is linked to myalgic encephalomeyelitis/chronic fatigue syndrome.